BMH-9 is a modulator of nuclear receptor subfamily 2, group F, member 6 (NR2F6), also known as the orphan nuclear receptor Ear2; it acts as an activator of the p53 signaling pathway, inhibits human cancer cell proliferation, and exhibits antitumor activity in NOD-SCID mouse models.